Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02190695
What this trial is testing

Leukemia SPORE Phase II DAC Study for R/R and Elderly Acute AML and MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromeChronic Myelomonocytic Leukemia
Fox Chase Cancer Center 92
Not applicableNot Yet RecruitingNCT07319793
What this trial is testing

Pre-DLI or Pro-DLI in Relapsed/Refractory Myeloid Neoplasms After HSCT

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes (MDS)
Peking University People's Hospital 200
Very early researchLooking for participantsNCT06201247
What this trial is testing

Off-the-shelf CD123 CAR-NK for R/R AML

Who this might be right for
Acute Myeloid Leukemia, in RelapseAcute Myeloid Leukemia Refractory
Peking University People's Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT05086315
What this trial is testing

First-in-human Study of SAR443579 Infusion in Male and Female Children and Adult Participants With Relapsed or Refractory Acute Myeloid Leukemia (R/R AML), B-cell Acute Lymphoblastic Leukemia (B-ALL), High Risk-myelodysplasia (HR-MDS), or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Who this might be right for
Acute Lymphocytic LeukaemiaAcute Myeloid Leukaemia RefractoryMyelodysplastic Syndromes+1 more
Sanofi 101
Not applicableNot Yet RecruitingNCT07572695
What this trial is testing

Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

Who this might be right for
Acute Myeloid LeukemiaRelapsed/Refractory Acute Myeloid LeukemiaAML, Relapsed/Refractory
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40
Testing effectiveness (Phase 2)UnknownNCT06532058
What this trial is testing

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)
Changzhou Qianhong Bio-pharma Co., Ltd. 53
Testing effectiveness (Phase 2)Ended earlyNCT03594955
What this trial is testing

First in Human Testing of Dose-escalation of SAR440234 in Patients With Acute Myeloid Leukemia, Acute Lymphoid Leukemia and Myelodysplastic Syndrome

Who this might be right for
Leukaemia
Sanofi 7
Early research (Phase 1)UnknownNCT05467254
What this trial is testing

Evaluate the Safety and Efficacy of CLL1+CD33 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Testing effectiveness (Phase 2)Temporarily pausedNCT02462265
What this trial is testing

Oshadi D & Oshadi R Combined With Salvage Chemotherapy for Relapsed Acute Myeloid Leukemia or Lymphoid Leukemia Patients

Who this might be right for
Acute Myeloid LeukemiaLymphoid Leukemia
Oshadi Drug Administration 15
Testing effectiveness (Phase 2)Looking for participantsNCT04065399
What this trial is testing

Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMixed Lineage Acute Leukemia+2 more
Syndax Pharmaceuticals 447
Large-scale testing (Phase 3)UnknownNCT05457361
What this trial is testing

VAH Versus VA for Salvage Therapy of R/R-AML

Who this might be right for
Venetoclax Combined With Azacitidine Plus HomoharringtonineVenetoclax Combined With Azacitidine
Nanfang Hospital, Southern Medical University 162
Very early researchUnknownNCT04803929
What this trial is testing

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

Who this might be right for
AML M4AML M5
Carbiogene Therapeutics Co. Ltd. 25
Testing effectiveness (Phase 2)WithdrawnNCT06586099
What this trial is testing

Tislelizumab with Azacitidine in the Treatment of R/R AML

Who this might be right for
Refractory AMLRelapsed Adult AML
Institute of Hematology & Blood Diseases Hospital, China
Very early researchNot Yet RecruitingNCT06702098
What this trial is testing

Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangzhou Ruixin Biotechnological Co., LTD 10
Early research (Phase 1)Study completedNCT05665530
What this trial is testing

PRT2527 as Monotherapy and in Combination With Zanubrutinib or Venetoclax in Participants With R/R Hematologic Malignancies

Who this might be right for
Aggressive B-Cell Non-Hodgkin's Lymphoma (NHL)Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Mantle Cell Lymphoma (MCL)+9 more
Prelude Therapeutics Incorporated 86
Early research (Phase 1)Active Not RecruitingNCT04603001
What this trial is testing

Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+1 more
Eli Lilly and Company 260
Early research (Phase 1)Study completedNCT04176393
What this trial is testing

A China Bridging Study of Ivosidenib in r/r AML Subjects With an IDH1 Mutation

Who this might be right for
Relapsed or Refractory Acute Myeloid Leukemia
CStone Pharmaceuticals 30
Early research (Phase 1)Not Yet RecruitingNCT07131085
What this trial is testing

QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and Myelodysplastic Syndromes(MDS)

Who this might be right for
MDSAML
Anhui Provincial Hospital 9
Testing effectiveness (Phase 2)UnknownNCT04669067
What this trial is testing

TL-895 and KRT-232 Study in Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Telios Pharma, Inc. 18
Early research (Phase 1)UnknownNCT05473221
What this trial is testing

Evaluate the Safety and Efficacy of CD33 CAR-T in Patients With R/R AML

Who this might be right for
AML
Zhejiang University 20
Next Page